Journal of Medicinal Chemistry p. 8202 - 8211 (2018)
Update date:2022-08-03
Topics:
Kharenko, Olesya A.
Patel, Reena G.
Brown, S. David
Calosing, Cyrus
White, Andre
Lakshminarasimhan, Damodharan
Suto, Robert K.
Duffy, Bryan C.
Kitchen, Douglas B.
McLure, Kevin G.
Hansen, Henrik C.
Van Der Horst, Edward H.
Young, Peter R.
BET proteins are key epigenetic regulators that regulate transcription through binding to acetylated lysine (AcLys) residues of histones and transcription factors through bromodomains (BDs). The disruption of this interaction with small molecule bromodomain inhibitors is a promising approach to treat various diseases including cancer, autoimmune and cardiovascular diseases. Covalent inhibitors can potentially offer a more durable target inhibition leading to improved in vivo pharmacology. Here we describe the design of covalent inhibitors of BRD4(BD1) that target a methionine in the binding pocket by attaching an epoxide warhead to a suitably oriented noncovalent inhibitor. Using thermal denaturation, MALDI-TOF mass spectrometry, and an X-ray crystal structure, we demonstrate that these inhibitors selectively form a covalent bond with Met149 in BRD4(BD1) but not other bromodomains and provide durable transcriptional and antiproliferative activity in cell based assays. Covalent targeting of methionine offers a novel approach to drug discovery for BET proteins and other targets.
View MoreShanghai Hongbang Medical Technology CO.,. Ltd
Contact:13671516988 /18917636693
Address:Room1, No67 Building, Yongde Road369, Wujing Town, Minhang Districy, Shanghai CIty, China.
Contact:0550-7041128 0550-7090578
Address:Wangdian Street,Xinjie Town
Contact:86 21 3772 9386
Address:Rm.1803,Starry Bldg.1,1505 Meijiabang Road,Shanghai 201620 China
Shanghai Yuking Water Soluble Material Tech Co., Ltd
Contact:86-21-68286299
Address:4F, 13B, No. 600, South Xinyuan Road 201306, Shanghai, China
Ningbo Distant Chemicals Co.,Ltd
Contact:86-574-27862490,27862438
Address:5F-3,#54 DaShaNi street,Ningbo,CHINA
Doi:10.1002/cmdc.201400049
(2014)Doi:10.1016/j.tetasy.2006.06.031
(2006)Doi:10.1016/0022-328X(94)05192-E
(1995)Doi:10.1038/s41557-020-0455-y
(2020)Doi:10.1021/ja953529i
(1996)Doi:10.1002/ejic.201402099
(2014)